A Randomized, double-blind, placebo controlled phase 3 study to evaluate the efficacy and safety of QPI-1002 for the prevention of major adverse kidney events (MAKE) in subjects at high risk for acute kidney injury (AKI) following cardiac surgery.

  • Udy, Andrew (Primary Chief Investigator (PCI))
  • Young, Meredith (Project Manager)

Project: Research

Project Details

Effective start/end date8/04/1931/12/24


  • Intensive care
  • Kidney injury
  • Cardiac surgery
  • Clinical trial